Korea vs Slovakia: Number of isolates tested for ceftriaxone
Korea
115
in 2018
Slovakia
108
in 2020
Korea rank
25th
Slovakia rank
28th
Number of isolates tested for ceftriaxone over time
- Korea
- Slovakia
How they compare
Korea currently reports 115 against 108 in Slovakia, a difference of 7.
That makes Korea's figure about 1.1 times Slovakia's.
The two have swapped places 2 times across 8 shared years of data; in 2009 it was Korea ahead.
Korea ranks 25th and Slovakia ranks 28th of 52 countries.
Across the 2 decades both report, Korea averaged higher in 1 and Slovakia in 1.
Head to head by decade
| Decade | Korea | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82 | 15 | 67 | Korea |
| 2010s | 64.71 | 101.71 | 37 | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Korea or Slovakia?
- Korea, at 115 against 108 in Slovakia as of 2018.
- What is the difference in number of isolates tested for ceftriaxone between Korea and Slovakia?
- 7, with Korea ahead.
- How many years of comparable data are there for Korea and Slovakia?
- 8 years are reported by both, from 2009 to 2018.
- How do Korea and Slovakia rank globally for number of isolates tested for ceftriaxone?
- Korea ranks 25th and Slovakia ranks 28th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.